Status:
COMPLETED
Reduction of Intraocular Pressure After I-stent By-pass Implantation in Eyes With Open Angle Glaucoma
Lead Sponsor:
Medical University of Bialystok
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose of this study is to exam the hypotensive effectiveness of I-stent implantation depended on number of antiglaucoma eye drops at baseline.
Detailed Description
The scientific aim of the project is to estimate the average reduction of intraocular pressure (IOP) in relation to the initial number of antiglaucoma drops at the end of 12 months observation period....
Eligibility Criteria
Inclusion
- co-existing glaucoma and cataract (NC1, NC2) classified by means of the LOCS III scale (Lens Opacity Classification System III)
- patients with primary open-angle glaucoma (POAG), pseudoexfoliative glaucoma (PGX) and normal tension glaucoma (NTG), with topical hypotensive treatment
- written consent to involvement and participation in the study for a period of at least 12 months was obtained from all patients after they had first been informed of the nature of the procedure and other surgical alternatives
Exclusion
- no consent to participation in the study
- prior surgical and laser procedures in the area of the eye
- narrow- or closed-angle glaucoma
- post-inflammatory or post-traumatic secondary glaucoma
- chronic illness of the cornea or optic nerve
- advanced macular degeneration
- active inflammatory process
- pregnancy
- systemic steroid therapy
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT03807869
Start Date
December 1 2018
End Date
February 1 2020
Last Update
February 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University
Bialystok, Poland, 15-089